David Leslie Szekeres's Net Worth
$212 Thousand
Who is David Leslie Szekeres?
David Leslie Szekeres does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include HERON THERAPEUTICS, INC. /DE/, Regulus Therapeutics Inc., and GRI BIO, Inc..
SEC CIK
David Leslie Szekeres's CIK is 0001602459
Past Insider Trading and Trends
2022 was David Leslie Szekeres's most active year for acquiring shares with 11 total transactions. David Leslie Szekeres's most active month to acquire stocks was the month of March. 2022 was David Leslie Szekeres's most active year for disposing of shares, totalling 12 transactions. David Leslie Szekeres's most active month to dispose stocks was the month of December. 2023 saw David Leslie Szekeres paying a total of $100,000.70 for 101,713 shares, this is the most they've acquired in one year. In 2021 David Leslie Szekeres cashed out on 11,120 shares for a total of $110,480.06, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HERON THERAPEUTICS, INC. /DE/ (HRTX) Snapshot price: $2.265
EVP, Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +12.69% | 3.8K |
$1.31 | -$2,635.72 | 33.75K |
Jul 13
| |||
Form 4
| +14.54% | 3.8K |
$2.88 | -$5,794.56 | 29.95K |
Apr 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
| +26.37% | 5.46K |
$3.22 | -$6,378.04 | 26.15K |
Oct 31 - Jan 13
| |||
Form 4
| +22.51% | 3.8K |
$3.76 | -$7,565.12 | 20.69K |
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 4
| +45.81% | 5.31K |
$3.43 | -$6,056.12 | 16.89K |
Apr 29 - Jul 13
| |||
Form 4
| +48.85% | 3.8K |
$6.07 | -$12,212.84 | 11.59K |
Apr 13
| |||
Form 4
| +95.50% | 3.8K |
$8.30 | -$16,699.60 | 7.78K |
Jan 13
| |||
Form 4
| +25.82% | 817 |
$10.55 | -$4,568.15 | 3.98K |
Oct 13
| |||
Form 4
| +287.27% | 2.35K |
$13.69 | -$5,836.84 | 3.16K |
Apr 30 - Jul 13
| |||
Form 4
|
∞
| 817 |
$16.66 | -$7,213.78 | 817 |
Apr 13
| |||
Form 4
|
—
|
0
|
$18.11 | -$22,641.86 |
0
|
Scheduled
|
Jan 13 - Jan 14
| ||
Form 4
| -100.00% | -3.57K |
$19.66 | -$70,219.43 |
0
|
Scheduled
|
Jan 8
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.37
Chief Business Officer & GC
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
GRI BIO, Inc. (GRI) Snapshot price: $1.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||